Development of Broadly Neutralizing Antibody Mimitopes for Characterization of CRF01_AE HIV-1 Antibody Responses

• Main Authors: Jesse V. Schoen, Lindsay Wieczorek, Syna Kuriakose Gift, Elizabeth J. Martinez, Sorachai Nitayaphan, Kriengkrai Srithanaviboonchai, Panita Pathipvanich, Brittani M. Barrows, Sebastian Molnar, Leigh Anne Eller, Nelson L. Michael, Sodsai Tovanabutra, Merlin L. Robb, Victoria R. Polonis
• Format: Article
• Language: English
• Published: International Biological and Medical Journals Publishing House Co., Limited 2017-10-01
• Series: Infectious Diseases and Translational Medicine
• Subjects: HIV-1; Neutralizing antibodies; Phage display; Biopanning; Mimitopes; Thailand
• Online Access: http://www.tran-med.com/EN/abstract/abstract49.shtml

Mapping humoral immune responses to HIV-1 over the course of natural infection is important in understanding epitope exposure in relation to elicitation of broadly neutralizing antibodies (bNAbs), which is considered imperative for effective vaccine design. When analyzing HIV-specific immune responses, the antibody binding profiles may be a correlate for functional antibody activity. In this study, we utilized phage display technology to identify novel mimitopes that may represent Env epitope structures bound by bNAbs directed at V1V2 and V3 domains, CD4 binding site (CD4bs) and the membrane proximal external region (MPER) of Env. Mimitope sequence motifs were determined for each bNAb epitope. Given the ongoing vaccine development efforts in Thailand, these mimitopes that represent CD4bs and MPER epitopes were used to map immune responses of HIV-1 CRF01_AE-infected individuals with known neutralizing responses from two distinct time periods, 1996-98 and 2012-15. The more contemporary cohort showed an increase in binding breadth with binding observed for all MPER and CD4bs mimitopes, while the older cohort showed only 75% recognition of the CD4bs mimitopes and no MPER mimotope binding. Furthermore, mimitope binding profiles correlated significantly with magnitude (p=0.0036) and breadth (p=0.0358) of neutralization of a multi-subtype Tier 1 panel of pseudoviruses. These results highlight the utility of this mimitope mapping approach for detecting human plasma IgG-specificities that target known neutralizing antibody epitopes, and may also provide an indication of the plasticity of antibody binding within HIV-1 Env neutralization determinants.